FIGURE

FIGURE 4

ID

ZDB-FIG-230606-9

Publication

Rodenas et al., 2023 - Venetoclax is a potent hepsin inhibitor that reduces the metastatic and prothrombotic phenotypes of hepsin-expressing colorectal cancer cells

Other Figures

All Figure Page

Back to All Figure Page

FIGURE 4

pSTAT3, pAKT and pERK1/2 expression in Caco-2 and Caco-2-HPN cells. Expression of pERK1/2 (A), pSTAT3 (B) and pAKT (C) determined by electrophoresis and Western blot in lysates of Caco-2 and Caco-2-HPN cells in triplicates. Levels were determined by densitometry and represented as relative protein expression to vinculin. Graphs represent the mean ± standard error of the mean of the triplicates. (D) Electrophoresis and Western blot of pSTAT3, pAKT and pERK1/2 in lysates of Caco-2 and Caco-2-HPN cells in triplicates. Vinculin expression was detected as loading control. pERK1/2, phospho-extracellular signal-regulated kinases 1 and 2; pSTAT3, phospho-signal transducer and activator of transcription 3; pAKT, phospho-Protein Kinase B; Caco-2-HPN, Caco-2 cells overexpressing hepsin; Caco-2, Caco-2 cells with hepsin basal expression; *: p-value < 0.05; HPN, Hepsin; +, overexpression; -, basal expression.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Front Mol Biosci